GSK2126458 (Omipalisib)
目录号: A11035
mTOR/PI3K 抑制剂,
GSK2126458 是一种高效、口服生物利用度的 PI3Kα 和 mTOR 抑制剂,在体内药效动力学和肿瘤生长效能模型中均显示活性。
Discription | GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A11035 |
---|---|
分子式 | C25H17F2N5O3S |
分子量 | 505.5 |
CAS号 | 1086062-66-9 |
SMILES | COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F |
其他名称 | GSK-2126458 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 96 mg/mL (189.91 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+40% PEG 300+2% Tween 80+ddH2O | 3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.78 mL | 98.91 mL | 197.82 mL |
0.5 mM | 3.96 mL | 19.78 mL | 39.56 mL |
1 mM | 1.98 mL | 9.89 mL | 19.78 mL |
5 mM | 0.4 mL | 1.98 mL | 3.96 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2